Crescita Therapeutics Inc: Falls on drop in quarterly revenue
** Shares of commercial dermatology co CTX.TO fall $8.5%
to 75 Canadian cents; set for biggest daily pct loss in nearly 6
months
** Q4 rev falls 26% to C$2.8 mln from yr-ago urn:newsml:reuters.com:*:nBw4ZYNlQa
** Reduction in aesthetic treatments and procedures in
Canada and internationally negatively impacted product sales of
premium skincare brands-CTX
** Net loss widens to C$592,000 from C$483,000
** YTD, stock up 7%
(Reporting by Shreyasee Raj in Bengaluru)
((Shreyasee.Raj@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium